You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Benefits of AZ vaccine outweigh risks, says MHRA

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that there is a possible link between AstraZeneca’s COVID-19 vaccine and “extremely rare, unlikely to occur blood clots”.